Catalyst Capital Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Catalyst Capital Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,300	Closed	-$523K	–	348
2019 Q4	$523K	Sell	11,300 -700	-6%	-$30.3K	0.02%	149
2019 Q3	$489K	Buy	12,000 +9,700	+422%	+$419K	0.02%	179
2019 Q2	$111K	Sell	2,300 -7,400	-76%	-$389K	﹤0.01%	205
2019 Q1	$607K	Sell	9,700 -3,200	-25%	-$220K	0.02%	172
2018 Q4	$770K	Buy	+12,900	New	+$775K	0.03%	155

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Catalyst Capital Advisors's BEAT Position: Q1 2020 in Review

Catalyst Capital Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 11,300 shares — an estimated $523K sold.

Catalyst Capital Advisors first reported a position in BEAT in Q4 2018 and held it in 5 quarters. The position peaked at $770K in Q4 2018. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

Catalyst Capital Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
Catalyst Capital Advisors sold 11,300 BioTelemetry, Inc. shares in Q1 2020, an estimated $523K.
Catalyst Capital Advisors first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 5 quarters.
Catalyst Capital Advisors's BioTelemetry, Inc. position peaked at $770K in Q4 2018.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Catalyst Capital Advisors's 13F filing for Q1 2020, filed 12 May 2020.